Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 12470 | 42.76 |
09:34 ET | 2700 | 42.625 |
09:36 ET | 1000 | 42.64 |
09:38 ET | 2263 | 43 |
09:39 ET | 2766 | 42.845 |
09:41 ET | 59586 | 43.09 |
09:43 ET | 1763 | 43.25 |
09:45 ET | 6824 | 43.37 |
09:48 ET | 1175 | 43.32 |
09:50 ET | 1299 | 43.5 |
09:52 ET | 2718 | 43.88 |
09:54 ET | 10900 | 43.72 |
09:56 ET | 22442 | 43.245 |
09:57 ET | 3600 | 43.6 |
09:59 ET | 700 | 43.546 |
10:01 ET | 200 | 43.515 |
10:03 ET | 2074 | 43.574 |
10:06 ET | 4699 | 43.88 |
10:08 ET | 2850 | 44 |
10:10 ET | 2903 | 44.34 |
10:12 ET | 1486 | 44.29 |
10:14 ET | 1665 | 44.42 |
10:15 ET | 8684 | 44.56 |
10:17 ET | 5350 | 44.55 |
10:19 ET | 3316 | 44.365 |
10:21 ET | 2820 | 44.48 |
10:24 ET | 7270 | 43.97 |
10:26 ET | 623 | 44.11 |
10:28 ET | 300 | 44.05 |
10:30 ET | 524 | 44.1 |
10:32 ET | 300 | 44.2399 |
10:33 ET | 4133 | 44.32 |
10:35 ET | 3300 | 44.345 |
10:37 ET | 6638 | 44.47 |
10:39 ET | 171 | 44.53 |
10:42 ET | 8108 | 44.47 |
10:44 ET | 1380 | 44.435 |
10:46 ET | 800 | 44.45 |
10:48 ET | 569 | 44.51 |
10:50 ET | 300 | 44.53 |
10:53 ET | 2123 | 44.405 |
10:55 ET | 709 | 44.37 |
10:57 ET | 225 | 44.4832 |
11:00 ET | 100 | 44.41 |
11:02 ET | 2264 | 44.455 |
11:04 ET | 13525 | 43.8976 |
11:06 ET | 100 | 43.91 |
11:08 ET | 1062 | 43.96 |
11:09 ET | 4197 | 43.59 |
11:11 ET | 3191 | 43.58 |
11:13 ET | 8303 | 43.52 |
11:15 ET | 1250 | 43.54 |
11:18 ET | 2206 | 43.69 |
11:20 ET | 900 | 43.81 |
11:22 ET | 200 | 43.73 |
11:24 ET | 1370 | 43.84 |
11:26 ET | 3174 | 43.84 |
11:27 ET | 4844 | 43.82 |
11:29 ET | 1900 | 43.785 |
11:31 ET | 5520 | 43.78 |
11:33 ET | 650 | 43.8 |
11:36 ET | 1400 | 43.8 |
11:38 ET | 232 | 43.8 |
11:40 ET | 1800 | 43.78 |
11:42 ET | 3411 | 43.73 |
11:44 ET | 550 | 43.69 |
11:45 ET | 200 | 43.69 |
11:47 ET | 200 | 43.69 |
11:49 ET | 500 | 43.65 |
11:51 ET | 1514 | 43.77 |
11:54 ET | 1693 | 43.785 |
11:56 ET | 400 | 43.78 |
12:00 ET | 5055 | 43.77 |
12:02 ET | 3609 | 43.83 |
12:03 ET | 250 | 43.8 |
12:05 ET | 600 | 43.84 |
12:07 ET | 300 | 43.77 |
12:09 ET | 2298 | 43.77 |
12:12 ET | 5042 | 43.71 |
12:14 ET | 421 | 43.705 |
12:16 ET | 400 | 43.75 |
12:18 ET | 588 | 43.785 |
12:20 ET | 3251 | 43.86 |
12:21 ET | 3500 | 43.86 |
12:23 ET | 200 | 43.815 |
12:25 ET | 900 | 43.86 |
12:30 ET | 100 | 43.82 |
12:32 ET | 400 | 43.82 |
12:36 ET | 3862 | 43.825 |
12:38 ET | 26559 | 43.78 |
12:39 ET | 3185 | 43.67 |
12:41 ET | 2533 | 43.69 |
12:43 ET | 12681 | 43.61 |
12:45 ET | 550 | 43.48 |
12:48 ET | 100 | 43.47 |
12:50 ET | 800 | 43.25 |
12:52 ET | 797 | 43.09 |
12:54 ET | 200 | 43.02 |
12:56 ET | 300 | 43.03 |
12:57 ET | 2300 | 43.11 |
12:59 ET | 800 | 43.255 |
01:01 ET | 220 | 43.255 |
01:03 ET | 542 | 43.255 |
01:06 ET | 305 | 43.24 |
01:08 ET | 700 | 43.31 |
01:10 ET | 100 | 43.33 |
01:12 ET | 1411 | 43.5 |
01:15 ET | 300 | 43.354 |
01:17 ET | 200 | 43.39 |
01:19 ET | 1895 | 43.505 |
01:21 ET | 18413 | 43.48 |
01:24 ET | 8544 | 43.53 |
01:26 ET | 1938 | 43.5 |
01:28 ET | 200 | 43.53 |
01:30 ET | 700 | 43.5396 |
01:32 ET | 703 | 43.53 |
01:33 ET | 1100 | 43.455 |
01:35 ET | 400 | 43.44 |
01:37 ET | 100 | 43.435 |
01:39 ET | 3463 | 43.31 |
01:42 ET | 600 | 43.31 |
01:44 ET | 100 | 43.32 |
01:46 ET | 300 | 43.4 |
01:48 ET | 203 | 43.36 |
01:51 ET | 400 | 43.44 |
01:53 ET | 200 | 43.55 |
01:55 ET | 633 | 43.71 |
01:57 ET | 750 | 43.82 |
02:00 ET | 200 | 43.82 |
02:02 ET | 1150 | 43.8 |
02:04 ET | 500 | 43.75 |
02:06 ET | 300 | 43.8599 |
02:08 ET | 200 | 43.795 |
02:09 ET | 3190 | 43.77 |
02:11 ET | 813 | 43.8 |
02:13 ET | 3720 | 43.73 |
02:15 ET | 3600 | 43.51 |
02:18 ET | 100 | 43.44 |
02:20 ET | 200 | 43.465 |
02:22 ET | 3648 | 43.4883 |
02:24 ET | 300 | 43.265 |
02:26 ET | 2940 | 43.3 |
02:29 ET | 1100 | 43.45 |
02:33 ET | 400 | 43.39 |
02:36 ET | 100 | 43.43 |
02:38 ET | 350 | 43.39 |
02:40 ET | 946 | 43.571 |
02:42 ET | 300 | 43.61 |
02:44 ET | 400 | 43.695 |
02:45 ET | 350 | 43.695 |
02:47 ET | 4000 | 43.58 |
02:49 ET | 100 | 43.58 |
02:51 ET | 950 | 43.5718 |
02:54 ET | 920 | 43.44 |
02:58 ET | 200 | 43.45 |
03:00 ET | 300 | 43.41 |
03:02 ET | 808 | 43.42 |
03:03 ET | 355 | 43.42 |
03:05 ET | 850 | 43.54 |
03:07 ET | 200 | 43.46 |
03:09 ET | 100 | 43.455 |
03:12 ET | 300 | 43.5 |
03:14 ET | 5513 | 43.29 |
03:16 ET | 300 | 43.285 |
03:18 ET | 200 | 43.285 |
03:20 ET | 900 | 43.37 |
03:21 ET | 324 | 43.41 |
03:23 ET | 663 | 43.43 |
03:25 ET | 1386 | 43.415 |
03:27 ET | 2000 | 43.43 |
03:30 ET | 630 | 43.405 |
03:32 ET | 338 | 43.405 |
03:34 ET | 4177 | 43.335 |
03:36 ET | 3905 | 43.4 |
03:38 ET | 10877 | 43.47 |
03:39 ET | 1055 | 43.5 |
03:41 ET | 4200 | 43.585 |
03:43 ET | 9751 | 43.58 |
03:45 ET | 1683 | 43.65 |
03:48 ET | 1200 | 43.57 |
03:50 ET | 1361 | 43.58 |
03:52 ET | 5356 | 43.72 |
03:54 ET | 900 | 43.71 |
03:56 ET | 5528 | 43.75 |
03:57 ET | 8667 | 43.84 |
03:59 ET | 46873 | 43.89 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.5B | -19.6x | --- |
Edgewise Therapeutics Inc | 2.5B | -17.4x | --- |
CG Oncology Inc | 2.5B | -32.3x | --- |
Immunitybio Inc | 2.6B | -4.0x | --- |
Vera Therapeutics Inc | 2.4B | -20.1x | --- |
SpringWorks Therapeutics Inc | 2.4B | -7.2x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.24 |
Book Value | $9.76 |
P/E Ratio | -19.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.